In vitro and in vivo anticancer activity of extracts, fractions, and eupomatenoid-5 obtained from Piper regnellii leaves

Planta Medica

Volumn 77, Issue 13, 2011, Pages 1482-1488

  Longato, Giovanna Barbarini ^a   Rizzo, Larissa Yokota ^a   De Oliveira Sousa, Ilza Maria ^a   Tinti, Sirlene Valério ^a   Possenti, Ana ^a   Figueira, Glyn Mara ^a   Ruiz, Ana Lúcia Tasca Gois ^a   Foglio, Mary Ann ^a   De Carvalho, João Ernesto ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Ehrlich solid tumor; eupomatenoid5; in vitro antiproliferative activity; neolignans; Piper regnellii (Miq.) C. DC. var. regnellii; Piperaceae

Indexed keywords

DICHLOROMETHANE; DOXORUBICIN; EUPOMATENOID 5; FLUOROURACIL; NEOLIGNAN; PIPER REGNELLII EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; BREAST CANCER; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CANCER; LEUKEMIA; LUNG CANCER; MEDICINAL PLANT; MELANOMA CELL; MOUSE; NONHUMAN; OVARY CANCER; PIPER REGNELLII; PROSTATE CANCER; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZOFURANS; CARCINOMA, EHRLICH TUMOR; CELL LINE, TUMOR; FEMALE; HUMANS; LIGNANS; MALE; MICE; MICE, INBRED BALB C; PHENOLS; PIPER; PLANT EXTRACTS; PLANT LEAVES;

MUS; PIPER REGNELLII; PIPERACEAE;

EID: 80052466778     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1270889     Document Type: Article

References (42)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M J. Cancer Statistics, 2009. CA Cancer J Clin 2009 59 225-249
2. Hanahan D, Weinberg R A. The hallmarks of cancer. Cell 2000 100 57-70 (Pubitemid 30046295)
3. Malhotra S, Singh A P. A review of pharmacology of phytochemicals from Indian medicinal plants. Available at. http://www.ispub.com/ostia/index.php? xmlFilePath=journals/ijam/vol5n1/phyto.xml Accessed January 10, 2011[nl]
4. Cragg G M., Newman D J. Nature: a vital source of leads for anticancer drug development. Phytochem Rev 2009 8 313-331
5. Benevides P J. C., Sartorellii P, Kato M J. Phenylpropanoids and neolignans from Piper regnellii. Phytochemistry 1999 52 339-343 (Pubitemid 29426501)
6. Lago J H. G., Chen A, Young M C. M., Guimarães E F., Oliveira A, Kato M J. Prenylated benzoic acid derivatives from Piper aduncum L. and P. hostmannianum C. DC. (Piperaceae). Phytochem Lett 2009 2 96-98
7. Tsai I L., Lee F P., Wu C C., Duh C Y., Ishikawa T, Chen J J., Chen Y C., Seki H, Chen I S. New cytotoxic cyclobutanoid amides, a new furanoid lignan and anti-platelet aggregation constituents from Piper arborescens. Planta Med 2005 71 535-542 (Pubitemid 40910600)
8. Déciga-Campos M, Rivero-Cruz I, Arriaga-Alba M, Castaneda-Corral G, Angeles-Lopez G E., Navarrete A, Mata R. Acute toxicity and mutagenic activity of Mexican plants used in traditional medicine. J Ethnopharmacol 2007 110 334-342
9. Lampe J W. Spicing up a vegetarian diet: chemopreventive effects of phytochemicals. Am J Clin Nutr 2003 78 5795-5835
10. Selvendiran K, Singh J P. V., Sakthisekaran D. In vivo effect of piperine on serum and tissue glycoprotein levels in benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice. Pulm Pharmacol Ther 2006 19 107-111 (Pubitemid 43052998)
11. Bezerra D P., Pessoa C, Moraes M O., Alencar N M. N., Mesquita R O., Lima M W., Pessoa O D. L., Chaves J H., Silveira E R., Costa-Lotufo L V. In vivo growth inhibition of sarcoma 180 by piperlonguminine, an alkaloid amide from the Piper species. J Appl Toxicol 2008 28 599-607 (Pubitemid 352009750)
12. Corrêa M P. Dicionário das Plantas Úteis do Brasil e das Exóticas Cultivadas. Rio de Janeiro Ministério da Agricultura, Instituto Brasileiro de Desenvolvimento Florestal 1984 373-374
13. Holetz F B., Pessini G L., Sanches N R., Cortez D A. G., Nakamura C V., Filho B P. D. Screening of some plants used in the Brazilian folk medicine for the treatment of infectious diseases. Mem Inst Oswaldo Cruz 2002 97 1027-1031 (Pubitemid 135747500)
14. Pessini G L., Dias Filho B P., Nakamura C V., Ferreira A G., Cortez D A. G. Neolignanas e análise do óleo essencial das folhas de Piper regnellii (Miq.) C. DC. var. pallescens (C. DC.) Yunck. Rev Bras Farmacogn 2005 15 199-204
15. Moss G P. Nomenclature of lignans and neolignans (IUPAC recommendations 2000). Pure Appl Chem 2000 72 1493-1523
16. Saleem M, Kim H J., Ali M S., Lee Y S. An update on bioactive plant lignans. Nat Prod Rep 2005 22 696-716 (Pubitemid 41830838)
17. Lee K-H, Xiao Z. Lignans in treatment of cancer and other diseases. Phytochem Rev 2003 2 341-362 (Pubitemid 41175235)
18. Trédan O, Galmarini C M., Patel K, Tannock I F. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 2007 99 1441-1454
19. Nascimento F R. F., Cruz G V. B., Pereira P V. S., Maciel M C. G., Silva L A., Azevedo A P. S., Barroqueiro E S. B., Guerra R N. M. Ascitic and solid Ehrlich tumor inhibition by Chenopodium ambrosioides L. treatment. Life Sci 2006 78 2650-2653 (Pubitemid 44313775)
20. Stewart H L. The cancer investigator. Cancer Res 1959 19 804-818
21. Sacoman J L., Monteiro K M., Possenti A, Figueira G M., Foglio M A., Carvalho J E. Cytotoxicity and antitumoral activity of dichloromethane extract and its fractions from Pothomorphe umbellata. Braz J Med Biol Res 2008 41 411-415
22. Shoemaker R H. The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 2006 6 813-823 (Pubitemid 44450469)
23. Fouche G, Cragg G M., Pillay P, Kolesnikova N, Maharaj V J., Senabe J. In vitro anticancer screening of South African plants. J Ethnopharmacol 2008 119 455-461
24. Lapa A J., Souccar C, Lima-Landman M T. R., Castro M S. A., Lima T C. M. Métodos de avaliação da atividade farmacológica de plantas medicinais. Porto Alegre Metrópole 2003
25. Litchfield J T., Wilcoxson F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949 96 99-113
26. Vendramini-Costa D B., de Castro I B., Ruiz A L., Marquissolo C, Pilli R A., de Carvalho J E. Effect of goniothalamin on the development of Ehrlich solid tumor in mice. Bioorg Med Chem 2010 18 6742-6747
27. Chauret D C., Bernard C B., Arnason J T., Durst T, Krishnamurty H G., Sanchez-Vindas P, Moreno N, San Roman L, Poveda L. Insecticidal neolignans from Piper decurrens. J Nat Prod 1996 59 152-155 (Pubitemid 27079833)
28. Longato G B. Atividade anticâncer de extratos brutos e fraçíes ativas obtidos de Piper regnellii (Miq). C. DC. var. regnellii [dissertation]. São Paulo Universidade Estadual de Campinas 2010
29. Tabudravu J N., Jaspars M. Anticancer activities of constituents of kava (Piper methysticum). South Pacific J Nat Sci 2005 23 26-29
30. Campos P B. C., Gama J J. T., Pereira L P., Costa-Lotufo L V., Moraes M O., Guimaraes E F., Kato M J., Furlan M, Pessoa C. Antitumor activity of extracts from Peperomia elongata. Pharm Biol 2007 45 760-765 (Pubitemid 350208830)
31. Majdalawieh A F., Carr R I. In vitro investigation of the potential immunomodulatory and anti-cancer activities of black pepper (Piper nigrum) and cardamom (Elettaria cardamomum). J Med Food 2010 13 371-381
32. Ruiz-Casado A, Garcia M D., Racionero M A. Pulmonary toxicity of 5-fluoracil and oxaliplatin. Clin Transl Oncol 2006 8 624
33. Verçosa Jr D, Melo M M., Cassali G D., Dantas-Barros A M., Silva Jr P G. P. Influência de Agaricus blazei Murrill sobre o tumor sólido de Ehrlich e linfonodos poplíteos de camundongos. Arq Bras Med Vet Zootec 2007 59 150-154 (Pubitemid 46741958)
34. Thompson L U. Experimental studies on lignans and cancer. Baillieres Clin Endocrinol Metab 1998 12 691-705 (Pubitemid 29261278)
35. Fan H F., Ren Y M., Wu X L., Wang Q A. Synthesis and cytotoxicity of novel benzofuran neolignans derivatives. J Chem Res 2010 34 233-235
36. McCann M J., Gill C I. R., McGlynn H, Rowland I R. Role of mammalian lignans in the prevention and treatment of prostate cancer. Nutr Cancer 2005 52 1-14 (Pubitemid 41232643)
37. Hedelin M, Lof M, Andersson T M- L., Adlercreutz H, Weiderpass E. Dietary phytoestrogens and the risk of ovarian cancer in the Women's Lifestyle and Health cohort study. Cancer Epidemiol Biomarkers
38. McCann S E., Thompson L U., Nie J, Dorn J, Trevisan M, Shields P G., Ambrosone C B., Edge S B., Li H F., Kasprzak C, Freudenheim J L. Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat 2010 122 229-235
39. Huang D M., Guh J H., Chueh S C., Teng C M. Modulation of anti-adhesion molecule MUC-1 is associated with arctiin-induced growth inhibition in PC-3 cells. Prostate 2004 59 260-267
40. Ward R S. Lignans, neolignans and related compounds. Nat Prod Rep 1997 14 43-74 (Pubitemid 27155959)
41. Nitiss J L. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer 2009 9 338-350
42. Baldwin E L., Osheroff N. Etoposide, topoisomerase II and cancer. Curr Med Chem Anticancer Agents 2005 5 363-372 (Pubitemid 40974810)